Major Review of 154,000 People Finds Calcium and Vitamin D Supplements Don't Prevent Fractures
A landmark BMJ review of 69 trials finds calcium and vitamin D supplements offer little to no protection against fractures or falls in older adults.
Summary
A sweeping review published in The BMJ analyzed data from nearly 154,000 adults across 69 randomized controlled trials and found that calcium supplements, vitamin D supplements, or a combination of both provided little to no meaningful reduction in fractures or falls for most older adults. This challenges decades of widespread medical guidance recommending these supplements for bone health. The findings held even after accounting for age, sex, prior fractures, and dietary calcium intake. Researchers note the results may not apply to people with specific bone disorders or those on osteoporosis medications, but the consistency across subgroups strengthens the overall conclusion that routine supplementation offers minimal protective benefit for the general older adult population.
Detailed Summary
For decades, calcium and vitamin D supplements have been a cornerstone recommendation for older adults hoping to protect their bones and reduce fall-related injuries. Millions take them daily on the advice of doctors, health guidelines, and regulatory agencies. A massive new review published in The BMJ now challenges that conventional wisdom with some of the strongest evidence to date.
Researchers in Canada pooled data from 69 randomized controlled trials involving 153,902 adults. The analysis compared calcium alone, vitamin D alone, and a combination of both against placebo or no treatment. The outcome measures focused on fracture risk and fall frequency — the two key harms these supplements are widely prescribed to prevent.
The results were striking in their consistency. Calcium supplementation showed little to no reduction in overall fracture risk, supported by moderate certainty evidence from 11 trials. Vitamin D alone showed similarly negligible benefit, backed by high certainty evidence from 36 trials covering over 92,000 participants. Combined supplementation fared no better, with high certainty evidence from 15 trials also showing minimal clinical impact. These findings extended to hip fractures specifically and to fall prevention.
Importantly, the null findings held across subgroup analyses stratified by age, sex, history of fractures, prior falls, and baseline dietary calcium intake. This robustness across different populations and conditions considerably strengthens the credibility of the conclusions.
Caveats remain. The review may not apply to individuals with diagnosed bone disorders such as osteoporosis being treated with medication, or those with known vitamin D deficiency. Some subanalyses were limited by fewer studies and smaller participant pools. Still, for otherwise healthy older adults taking these supplements purely as a preventive measure, the evidence now suggests this common practice offers little measurable bone protection and warrants a serious reassessment by both clinicians and patients.
Key Findings
- Calcium supplements showed little to no fracture reduction in older adults across 11 trials and 9,067 participants.
- Vitamin D alone provided no meaningful fracture or fall protection in 36 trials covering over 92,000 people.
- Combined calcium and vitamin D supplementation also failed to reduce fractures or falls with high certainty evidence.
- Null findings were consistent across age, sex, prior fracture history, and dietary calcium intake subgroups.
- Results may not apply to people with osteoporosis diagnoses or known vitamin D deficiency being medically treated.
Methodology
This is a research summary reporting on a systematic review and meta-analysis published in The BMJ, a high-impact peer-reviewed journal. The evidence base includes 69 randomized controlled trials with nearly 154,000 participants, assessed using established bias and certainty evaluation methods. The source is ScienceDaily reporting on a BMJ Group publication, which is credible but the full primary paper should be consulted for complete methodology.
Study Limitations
The article does not reproduce the full study text, so specific dosing regimens, supplementation durations, and baseline vitamin D levels across trials cannot be evaluated here. Findings may not generalize to individuals with clinical deficiencies or active bone disease. Readers should access the primary BMJ publication to assess individual trial quality and dose-response data before making personal health decisions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.